drugset / Trial / NCT05080946
Using Aspirin to Improve Immunological Features of Ovarian Tumors
Phase 0
Recruiting
100 enrolled
H. Lee Moffitt Cancer Center and Research Institute
Sharp · collabUnited States Department of Defense · collab
RandomizedSingle-groupTriple-blindTreatment
Summary
The purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking surgery, in women with diagnosed ovarian, fallopian tube, or peritoneal carcinoma
Timeline
- Start
- 2021-11-02
- Primary completion
- 2026-07
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 325 mg | Oral |